Regulation of LYRM1 gene expression by free fatty acids, adipokines, and rosiglitazone in 3T3-L1 adipocytes

Exp Diabetes Res. 2012:2012:820989. doi: 10.1155/2012/820989. Epub 2011 Oct 26.

Abstract

LYR motif containing 1 (LYRM1) is a novel gene that is abundantly expressed in the adipose tissue of obese subjects and is involved in insulin resistance. In this study, free fatty acids (FFAs) and tumor necrosis factor-α (TNF-α) are shown to upregulate LYRM1 mRNA expression in 3T3-L1 adipocytes. Conversely, resistin and rosiglitazone exert an inhibitory effect on LYRM1 mRNA expression. These results suggest that the expression of LYRM1 mRNA is affected by a variety of factors that are related to insulin sensitivity. LYRM1 may be an important mediator in the development of obesity-related insulin resistance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3T3-L1 Cells
  • Adipokines / pharmacology*
  • Animals
  • Apoptosis Regulatory Proteins / genetics*
  • Fatty Acids, Nonesterified / pharmacology*
  • Gene Expression Regulation / drug effects*
  • Insulin Resistance / genetics
  • Mice
  • RNA, Messenger / analysis
  • Resistin / pharmacology
  • Rosiglitazone
  • Thiazolidinediones / pharmacology*
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • Adipokines
  • Apoptosis Regulatory Proteins
  • Fatty Acids, Nonesterified
  • LYR motif containing 1 protein, mouse
  • RNA, Messenger
  • Resistin
  • Thiazolidinediones
  • Tumor Necrosis Factor-alpha
  • Rosiglitazone